The Opportunity
The heart of insitro’s strategy is the combination of novel, cutting edge methods in machine learning, biology at scale and small molecule discovery that address key bottlenecks in the drug development pipeline. To accomplish that, we are putting together an incredible team of highly talented drug discovery scientists who want to make a difference to these important problems. In this key role, you will help build the DMPK/ADME group and Drug Discovery department. Your primary duties will include (i) guide DMPK/ADME efforts in projects as lead and/or project team leader (ii) work cross-functionally to drive drug discovery projects through different stage gates towards clinical development candidates (iii) lead DMPK/ADME CRO efforts (iv) explore new approaches to utilize machine learning in drug discovery with a particular focus on DMPK/ADME
You will be joining a growing biotech startup that has long-term stability due to significant funding, but yet is very much in formation. A lot can change in this early and exciting phase, providing many opportunities for significant impact. You will work closely with a very talented team, learn a broad range of skills, and help shape insitro’s culture, strategic direction, and outcomes. Join us, and help make a difference to patients!
About You
- PhD in pharmaceutical science, pharmacokinetics, drug metabolism or a related field with 8+ years of experience in biotech/pharmaceutical discovery and development
- Comprehensive understanding and scientific knowledge of DMPK/ADME, PK/PD and drug development processes
- Demonstrated track record of leading role in advancing projects through different stages of drug discovery
- Track record of innovation and impact on projects through peer-reviewed publication and/or patent applications
- High level of creativity and productivity towards solving complex DMPK/ADME problems
- Extensive working knowledge of drug discovery principles and techniques beyond DMPK/ADME
- Experience managing scientific collaboration and CRO resources
- Excellent written and verbal communication skills across multi-functional teams
- Intellectual curiosity to push the boundaries of drug discovery
Compensation & Benefits at insitro
Our target starting salary for successful US-based applicants for this role is $215,000 - $235,000. To determine starting pay, we consider multiple job-related factors including a candidate’s skills, education and experience, the level at which they are actually hired, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.
This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.
In addition, insitro also provides our employees:
- 401(k) plan with employer matching for contributions
- Excellent medical, dental, and vision coverage (insitro pays 100% of premiums for employees), as well as mental health and well-being support
- Open, flexible vacation policy
- Paid parental leave
- Quarterly budget for books and online courses for self-development
- Support to occasionally attend professional conferences that are meaningful to your career growth and development
- New hire stipend for home office setup
- Monthly cell phone & internet stipend
- Access to free onsite baristas and cafe with daily lunch and breakfast
- Access to free onsite fitness center
- Commuter benefits
#LI-DH1
#LI-Hybrid
About insitro
insitro is a data-driven drug discovery and development company using machine learning and data at scale to transform the way that drugs are discovered and developed for patients. insitro is developing predictive machine learning models to discover underlying biologic state based on human cohort data and in-house generated cellular data at scale. These predictive models can be brought to bear on key bottlenecks in pharmaceutical R&D to advance novel targets and patient biomarkers, design therapeutics, and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of biologic insights and molecules in neuroscience and metabolic diseases. Since formation in mid 2018, insitro has raised over $700 million from top tech, biotech, and crossover investors and from collaborations with pharmaceutical partners. For more information on insitro, please visit the company’s website at www.insitro.com .